Processes, communication, the standard system of providing healthcare, and especially relationships … it’s all been disrupted by the COVID-19 pandemic. Pharma marketers — heck, all of us — continue to live and work in a state of evolution and uncertainty. What hasn’t changed, though, is the importance of connections, relationships, and the flow of information between the pharmaceutical industry, healthcare professionals (HCPs), and patients.

Last fall, with all this in mind, Intouch Group and DHC Group conducted quantitative and qualitative research to look at how pharma sales and marketing had been impacted. The goal was to answer the question, “What can pharmaceutical marketers do now to effectively engage their audiences, and what should they be thinking of next?” The outcome was a 70-page whitepaper. If you don’t have time to sit down with our complete report, read this op ed from John Kenny, Intouch Group’s head of strategic planning, which breaks it down and provides the key takeaways.